News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
531,662 Results
Type
Article (45033)
Company Profile (117)
Press Release (486512)
Multimedia
Podcasts (82)
Webinars (12)
Section
Business (145747)
Career Advice (2403)
Deals (28081)
Drug Delivery (120)
Drug Development (68170)
Employer Resources (151)
FDA (15692)
Job Trends (12040)
News (264931)
Policy (29746)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2314)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (79)
Alliances (36199)
ALS (87)
Alzheimer's disease (1433)
Antibody-drug conjugate (ADC) (134)
Approvals (15650)
Artificial intelligence (238)
Autoimmune disease (27)
Automation (12)
Bankruptcy (312)
Best Places to Work (9262)
BIOSECURE Act (22)
Biosimilars (114)
Biotechnology (70)
Bladder cancer (79)
Brain cancer (26)
Breast cancer (257)
Cancer (2094)
Cardiovascular disease (185)
Career advice (2009)
Career pathing (33)
CAR-T (141)
Cell therapy (402)
Cervical cancer (19)
Clinical research (55455)
Collaboration (705)
Compensation (523)
Complete response letters (29)
COVID-19 (2598)
CRISPR (42)
C-suite (216)
Cystic fibrosis (94)
Data (1976)
Decentralized trials (2)
Denatured (14)
Depression (50)
Diabetes (263)
Diagnostics (5275)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (101)
Drug pricing (121)
Drug shortages (30)
Duchenne muscular dystrophy (98)
Earnings (58942)
Editorial (43)
Employer branding (20)
Employer resources (136)
Events (77468)
Executive appointments (648)
FDA (16896)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (636)
Gene editing (102)
Generative AI (22)
Gene therapy (307)
GLP-1 (787)
Government (3917)
Grass and pollen (6)
Guidances (48)
Healthcare (15023)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (136)
Indications (26)
Infectious disease (2744)
Inflammatory bowel disease (129)
Inflation Reduction Act (9)
Influenza (49)
Intellectual property (88)
Interviews (449)
IPO (14018)
IRA (48)
Job creations (3160)
Job search strategy (1668)
Kidney cancer (11)
Labor market (32)
Layoffs (509)
Leadership (21)
Legal (6984)
Liver cancer (72)
Lung cancer (296)
Lymphoma (145)
Machine learning (6)
Management (51)
Manufacturing (287)
MASH (69)
Medical device (11295)
Medtech (11298)
Mergers & acquisitions (14560)
Metabolic disorders (717)
Multiple sclerosis (73)
NASH (22)
Neurodegenerative disease (95)
Neuropsychiatric disorders (33)
Neuroscience (1952)
NextGen: Class of 2025 (5050)
Non-profit (3191)
Northern California (2429)
Now hiring (17)
Obesity (398)
Opinion (218)
Ovarian cancer (66)
Pain (84)
Pancreatic cancer (76)
Parkinson's disease (146)
Partnered (16)
Patents (228)
Patient recruitment (97)
Peanut (44)
People (42894)
Pharmaceutical (33)
Pharmacy benefit managers (21)
Phase I (16595)
Phase II (24004)
Phase III (19722)
Pipeline (1138)
Policy (164)
Postmarket research (2210)
Preclinical (6703)
Press Release (28)
Prostate cancer (104)
Psychedelics (35)
Radiopharmaceuticals (210)
Rare diseases (390)
Real estate (4285)
Recruiting (60)
Regulatory (20994)
Reports (31)
Research institute (2070)
Resumes & cover letters (401)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (74)
Series A (122)
Series B (79)
Service/supplier (9)
Sickle cell disease (54)
Southern California (2055)
Special edition (16)
Spinal muscular atrophy (134)
Sponsored (33)
Startups (2750)
State (1)
Stomach cancer (16)
Supply chain (71)
Tariffs (39)
The Weekly (67)
United States (20314)
Vaccines (760)
Venture capitalists (43)
Weight loss (291)
Women's health (31)
Worklife (19)
Date
Today (209)
Last 7 days (772)
Last 30 days (2366)
Last 365 days (29899)
2025 (9496)
2024 (31454)
2023 (35058)
2022 (45209)
2021 (48651)
2020 (45742)
2019 (36508)
2018 (27620)
2017 (27873)
2016 (25867)
2015 (28076)
2014 (21851)
2013 (17859)
2012 (19070)
2011 (19485)
2010 (17574)
Location
Africa (673)
Alabama (41)
Alaska (6)
Arizona (169)
Arkansas (10)
Asia (31131)
Australia (5464)
California (5444)
Canada (1495)
China (408)
Colorado (234)
Connecticut (266)
Delaware (129)
Europe (75773)
Florida (825)
Georgia (181)
Hawaii (1)
Idaho (38)
Illinois (432)
India (24)
Indiana (243)
Iowa (11)
Japan (142)
Kansas (83)
Kentucky (13)
Louisiana (7)
Maine (61)
Maryland (825)
Massachusetts (4117)
Michigan (176)
Minnesota (322)
Mississippi (1)
Missouri (70)
Montana (12)
Nebraska (19)
Nevada (59)
New Hampshire (50)
New Jersey (1550)
New Mexico (14)
New York (1520)
North Carolina (880)
North Dakota (6)
Northern California (2429)
Ohio (154)
Oklahoma (8)
Oregon (28)
Pennsylvania (1182)
Puerto Rico (9)
Rhode Island (20)
South America (1038)
South Carolina (20)
South Dakota (1)
Southern California (2055)
Tennessee (90)
Texas (766)
Utah (142)
Virginia (128)
Washington D.C. (59)
Washington State (500)
West Virginia (3)
Wisconsin (51)
531,662 Results for "ambu a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
CMS Grants Transitional Pass-Through (TPT) Payment for Ambu’s aScope 5 Broncho HD Single-Use Bronchoscope
Ambu Inc. announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has granted the company’s aScope 5 Broncho HD a transitional pass-through (TPT) payment.
December 6, 2023
·
5 min read
BioCapital
Ohio Physician Becomes the First Doctor in the U.S. to Use Ambu’s Single-Use Duodenoscope in 100 Procedures
Ambu Inc., the world leader in single-use endoscopy, announced that an Ohio gastroenterologist has become the first physician in the U.S. to use Ambu’s new sterile, single-use duodenoscope in 100 endoscopic retrograde cholangiopancreatography procedures.
November 4, 2021
·
4 min read
FDA
Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit
Today, Ambu announces the 510(k) regulatory clearance of the Ambu® aScope™ Gastro and Ambu® aBox™ 2 in the United States. aScope Gastro is Ambu’s first sterile single-use gastroscope and includes new advanced imaging and design features in a combined solution with next-generation display and processor technology.
February 4, 2022
·
4 min read
BioCapital
Ambu Expands Access to Over 1 Million Procedures in the ENT Segment
Ambu continues to advance the market for single-use endoscopy by addressing Fibreoptic Endoscopic Evaluation of Swallowing.
April 19, 2022
·
3 min read
Podcast
Tariff Turmoil, FDA’s Future, Pfizer’s Obesity Setback and CEO Salaries Revealed
Donald Trump takes biopharma on a tariff-themed rollercoaster ride; J&J kicks off the Q1 earnings season; experts express concern about the FDA’s future; Pfizer’s obesity setback could be Viking’s gain; and BioSpace reveals the highest paid pharma CEOs.
April 16, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Pixee Medical Receives FDA 510(k) Clearance for Augmented Reality solution tailored to U.S. Ambulatory Surgery Centers
April 22, 2025
·
3 min read
BioCapital
Ambu Awarded National Video Laryngoscope Contract with Vizient Inc.
Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract in the category of Video Laryngoscopes with Vizient Inc.
November 29, 2021
·
3 min read
BioCapital
Ambu Awarded National Single-Use Endoscopy Contract with Vizient, Inc.
Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract in the category of Single-Use Visualization Devices with Vizient Inc., the largest healthcare performance improvement company in the U.S.
December 6, 2021
·
3 min read
Tariffs
Trump’s Tariffs Could Challenge Pharma’s Recession-Resistant Reputation
Long considered resistant to economic downturns, the pharmaceutical industry may face a greater challenge this time around as GLP-1s dominate and the population grows older.
April 8, 2025
·
5 min read
·
Annalee Armstrong
Alzheimer’s disease
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi
The European Union’s CHMP said that the benefits of the drug, already approved in the U.S., do not outweigh the risk of potentially fatal brain swelling and bleeding.
March 28, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 53,167
Next
